- Investing Ideas
- Global Biotech Breakthroughs
Global Biotech Breakthroughs
Results
85
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
85 companies
Heron Therapeutics
Market Cap: US$192.3m
A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.
HRTX
US$1.02
7D
6.6%
1Y
-53.6%
Caris Life Sciences
Market Cap: US$5.9b
An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
CAI
US$20.50
7D
-2.1%
1Y
n/a
CareDx
Market Cap: US$1.1b
Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
CDNA
US$20.63
7D
17.4%
1Y
15.6%
Immunocore Holdings
Market Cap: US$1.5b
Engages in the development and commercialization of immunomodulating medicines for patients with cancer, infectious diseases, and autoimmune disease in the United States, Europe, and internationally.
IMCR
US$29.98
7D
-5.2%
1Y
0.6%
Vitrolife
Market Cap: SEK 14.5b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 106.80
7D
0.3%
1Y
-31.7%
SynAct Pharma
Market Cap: SEK 974.4m
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 17.40
7D
-0.7%
1Y
-3.3%
Candel Therapeutics
Market Cap: US$512.7m
A clinical stage biopharmaceutical company, develops immunotherapies for cancer patients.
CADL
US$7.34
7D
42.5%
1Y
54.2%
Aroa Biosurgery
Market Cap: AU$190.2m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.51
7D
-1.0%
1Y
30.8%
Protalix BioTherapeutics
Market Cap: US$178.9m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$2.20
7D
-7.6%
1Y
-25.7%
Zymeworks
Market Cap: US$2.1b
A biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases.
ZYME
US$28.53
7D
2.9%
1Y
129.2%
Amicus Therapeutics
Market Cap: US$4.5b
A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.
FOLD
US$14.46
7D
0%
1Y
103.7%
Natera
Market Cap: US$29.1b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$207.78
7D
0.3%
1Y
39.9%
Poltreg
Market Cap: zł78.6m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł16.85
7D
0.6%
1Y
-53.2%